Asset Manager

Updated:

YX Genomics Holding Corporation

YX Genomics Holding Corporation is a U.S.-registered entity, incorporated with no publicly disclosed founding year or founding figure. The firm's name points...

YX Genomics Holding Corporation

YX Genomics Holding Corporation is a U.S.-registered entity, incorporated with no publicly disclosed founding year or founding figure. The firm's name points toward genomics or life sciences, but its wealth origin — whether self-funded, family-backed, or institutional — is not on record. No strategy, asset-class mix, or stage coverage is available. The entity has not confirmed any portfolio companies, co-investors, or deal structures. No geographic footprint beyond its U.S. registration has been identified. As of May 2026, the firm has no known team size, additional offices, or adjacent vehicles. No operational events from the last 24 months are publicly recorded. The primary structural differentiator for YX Genomics Holding Corporation is its near-total lack of public information. This opacity may be deliberate or simply a reflection of a pre-operational or dormant entity.

General information

Firm type

Asset Manager

Location

Region

North America

Country

United States

Corporate office

United States

Frequently asked questions

Does YX Genomics Holding Corporation disclose any AUM or deployment figures?

The firm has not publicly reported any AUM, deployment, or financial metrics. No regulatory filings or press releases were found that detail its asset base.

What is the legal or regulatory posture of YX Genomics Holding Corporation?

The firm is registered as a holding corporation in the U.S., but no SEC filings, investment adviser disclosures, or other regulatory documents were found. Its status as an active investment vehicle cannot be verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Asset Manager profiles